awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37408595-60A3F9AE-2E6A-4CCA-B591-925AD9EA6FD1
Q37408595-60A3F9AE-2E6A-4CCA-B591-925AD9EA6FD1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37408595-60A3F9AE-2E6A-4CCA-B591-925AD9EA6FD1
Therapeutic efficacy and safety of S-1-based combination therapy compare with S-1 monotherapy following gemcitabine failure in pancreatic cancer: a meta-analysis
P2860
Q37408595-60A3F9AE-2E6A-4CCA-B591-925AD9EA6FD1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37408595-60A3F9AE-2E6A-4CCA-B591-925AD9EA6FD1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
552a756e150e71ccebd1b3051d5cc03cdf65bacc
P2860
Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed.